Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms

Copyright © 2018 Elsevier Inc. All rights reserved..

We hypothesized that dopamine neuromodulation might affect cortical excitability in Parkinson's disease (PD) patients set in quiet wakefulness, as revealed by resting state eyes-closed electroencephalographic (rsEEG) rhythms at alpha frequencies (8-12 Hz). Clinical and rsEEG rhythms in PD with dementia (N = 35), PD with mild cognitive impairment (N = 50), PD with normal cognition (N = 35), and normal (N = 50) older adults were available from an international archive. Cortical rsEEG sources were estimated by exact low-resolution brain electromagnetic tomography. Compared with the normal older group, the PD groups showed reduced occipital alpha sources and increased widespread delta (<4 Hz) sources. Widespread frontal and temporal alpha sources exhibited an increase in PD with dementia compared with PD with mild cognitive impairment and PD with normal cognition groups, as function of dopamine depletion severity, typically greater in the former than the latter groups. A daily dose of levodopa induced a widespread reduction in cortical delta and alpha sources in a subgroup of 13 PD patients under standard chronic dopaminergic regimen. In PD patients in quiet wakefulness, alpha cortical source activations may reflect an excitatory effect of dopamine neuromodulation.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:73

Enthalten in:

Neurobiology of aging - 73(2019) vom: 21. Jan., Seite 9-20

Sprache:

Englisch

Beteiligte Personen:

Babiloni, Claudio [VerfasserIn]
Del Percio, Claudio [VerfasserIn]
Lizio, Roberta [VerfasserIn]
Noce, Giuseppe [VerfasserIn]
Lopez, Susanna [VerfasserIn]
Soricelli, Andrea [VerfasserIn]
Ferri, Raffaele [VerfasserIn]
Pascarelli, Maria Teresa [VerfasserIn]
Catania, Valentina [VerfasserIn]
Nobili, Flavio [VerfasserIn]
Arnaldi, Dario [VerfasserIn]
Famà, Francesco [VerfasserIn]
Orzi, Francesco [VerfasserIn]
Buttinelli, Carla [VerfasserIn]
Giubilei, Franco [VerfasserIn]
Bonanni, Laura [VerfasserIn]
Franciotti, Raffaella [VerfasserIn]
Onofrj, Marco [VerfasserIn]
Stirpe, Paola [VerfasserIn]
Fuhr, Peter [VerfasserIn]
Gschwandtner, Ute [VerfasserIn]
Ransmayr, Gerhard [VerfasserIn]
Fraioli, Lucia [VerfasserIn]
Parnetti, Lucilla [VerfasserIn]
Farotti, Lucia [VerfasserIn]
Pievani, Michela [VerfasserIn]
D'Antonio, Fabrizia [VerfasserIn]
De Lena, Carlo [VerfasserIn]
Güntekin, Bahar [VerfasserIn]
Hanoğlu, Lutfu [VerfasserIn]
Yener, Görsev [VerfasserIn]
Emek-Savaş, Derya Durusu [VerfasserIn]
Triggiani, Antonio Ivano [VerfasserIn]
Taylor, John Paul [VerfasserIn]
McKeith, Ian [VerfasserIn]
Stocchi, Fabrizio [VerfasserIn]
Vacca, Laura [VerfasserIn]
Frisoni, Giovanni B [VerfasserIn]
De Pandis, Maria Francesca [VerfasserIn]

Links:

Volltext

Themen:

46627O600J
Antiparkinson Agents
Functional brain connectivity
Journal Article
Levodopa
Mild cognitive impairment due to Alzheimer's disease (ADMCI)
Mild cognitive impairment due to Parkinson's disease (PDMCI)
Research Support, Non-U.S. Gov't
Resting state EEG rhythms

Anmerkungen:

Date Completed 19.12.2019

Date Revised 19.12.2019

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.neurobiolaging.2018.08.010

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM289476925